1.
Ali A, Rota L, Marshall K, Yao Y, Ji R, DeFilipp Z. Belumosudil achieves clinical response in chronic graft-versus-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial. Haematologica; https://doi.org/10.3324/haematol.2026.301043 [Early view].